News | November 18, 2022
Apollo launches national program to promote rational use of antibiotics
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Program will fight the rising incidence of antimicrobial (drug) resistance and improve patient outcomes
Micafungin for Injection had annual sales of US $99 million in the United States according to IQVIA data
Separate Phase 3 study evaluating 200 days of therapy with PREVYMIS in HSCT recipients at high risk of late clinically significant CMV infection recently completed, meeting its primary endpoint
CHMP positive opinion is based on evidence from the EFFISAYIL trial, the largest clinical trial in
The requirement of blood in India is estimated to be 8.5 million to 10 million units/per year, whereas the available supply is only 7.4 million units/per year
UNICEF award is worth US $98.755 million for supply of around 99.70 million doses during calendar years 2023-2027
Kokilaben Hospital is also the first hospital in Navi Mumbai to receive the SMART ICU certification
The reliability of their products, evidenced by their inclusion in the WHO emergency use list, has further improved with the addition of Takara Bio's enzymes.
Japan’s Ministry of Health, Labour and Welfare (MHLW) has recently approved AstraZeneca's long-acting antibody combination “Evusheld” for the prevention ) and treatment of COVID-19.
WCK 5222 is a Super-drug which is entirely a new class of antibiotic known as "?-lactam ENHANCER".
Subscribe To Our Newsletter & Stay Updated
